Search

Search Results

3 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 16, Issue 3pp 2812-2827

  Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer

  Relevance score: 0.00

  Jingsong Wang, Zhengyu Jiang, Kai Wang, Qingyuan Zheng, Jun Jian, Xiuheng Liu, Zhiyuan Chen, Rui Yang, Lei Wang

  Keywords: bladder cancer, necroptosis, lncRNA signature, survival, immune microenvironment, chemotherapeutic response

  Published in Aging on February 5, 2024

  Show abstract
• Research PaperVolume 15, Issue 11pp 4844-4860

  A novel predictive model based on inflammatory response-related genes for predicting endometrial cancer prognosis and its experimental validation

  Relevance score: 0.00

  Yuting Wang, Bo Wang, Xiaoxin Ma

  Keywords: endometrial carcinoma, inflammatory response-related genes (IRGs), prognostic model, immunotherapy response, chemotherapeutic drug sensitivity

  Published in Aging on June 5, 2023

  Show abstract
• Research PaperVolume 14, Issue 8pp 3365-3386

  Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

  Relevance score: 0.00

  James A. McCubrey, Akshaya K. Meher, Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Michelle M. LaHair, Richard A. Franklin, Alberto M. Martelli, Stefano Ratti, Lucio Cocco, Fulvio Barbaro, Przemysław Duda, Agnieszka Gizak

  Keywords: TP53, targeted therapy, PDAC, chemotherapeutic drugs, metabolic properties

  Published in Aging on April 27, 2022

  Show abstract